Sign in
4

Changes in Ownership

TriSalus Life Sciences, Inc. Filed Acc 0001410289-25-000006

CEO and President acquired 550,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Szela Mary T CEO and President 2024-02-13 Grant or award +125,000 317,802 D: show line 1 in the form
Szela Mary T CEO and President 2025-11-24 Grant or award +125,000 442,802 D: show line 2 in the form
Szela Mary T CEO and President 2025-11-24 Grant or award +300,000 742,802 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Szela Mary T CEO and President 2025-11-24 Grant or award · Employee Stock Option (right to buy) +250,000 1,578,182 D: show line 4 in the form
Loading xslF345X05/wk-form4_1764104104.xml…